More directly, loss of p53 or Smad4 largely enhances the progression of prostate cancer and contributes to metastatic prostate cancer by overcoming senescence-induced by Pten deletion (7, 10). The gene discussed is PTEN; the disease is metastatic prostate carcinoma.